Follow
Sophie M. Poznanski
Sophie M. Poznanski
PhD Candidate, McMaster Immunology Research Centre, McMaster University
Verified email at mcmaster.ca - Homepage
Title
Cited by
Cited by
Year
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
SM Poznanski, K Singh, TM Ritchie, JA Aguiar, IY Fan, AL Portillo, ...
Cell Metabolism 33 (6), 1205-1220. e5, 2021
1372021
What defines NK cell functional fate: phenotype or metabolism?
SM Poznanski, AA Ashkar
Frontiers in immunology 10, 465987, 2019
1082019
M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner
T Krneta, A Gillgrass, S Poznanski, M Chew, AJ Lee, M Kolb, AA Ashkar
Journal of Leucocyte Biology 101 (1), 285-295, 2017
942017
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
E Lusty, SM Poznanski, K Kwofie, TS Mandur, DA Lee, CD Richards, ...
Molecular immunology 88, 138-147, 2017
782017
Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function
SM Poznanski, NG Barra, AA Ashkar, JD Schertzer
Inflammation research 67, 813-828, 2018
622018
Asthma exacerbations on benralizumab are largely non‐eosinophilic.
SM Poznanski, M Mukherjee, N Zhao, C Huang, K Radford, AA Ashkar, ...
Allergy 76 (1), 2021
492021
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
T Nham, SM Poznanski, IY Fan, MM Shenouda, MV Chew, AJ Lee, ...
Cancer Immunology, Immunotherapy 67, 575-587, 2018
432018
Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model
SM Poznanski, T Nham, MV Chew, AJ Lee, JA Hammill, IY Fan, M Butcher, ...
Cancer immunology research 6 (10), 1174-1185, 2018
422018
Aging and interferons: impacts on inflammation and viral disease outcomes
E Feng, E Balint, SM Poznanski, AA Ashkar, M Loeb
Cells 10 (3), 708, 2021
412021
Ex vivo-expanded natural killer cells derived from long-term cryopreserved cord blood are cytotoxic against primary breast cancer cells
T Nham, SM Poznanski, IY Fan, F Vahedi, MM Shenouda, AJ Lee, ...
Journal of Immunotherapy 41 (2), 64-72, 2018
402018
Combined stimulation with interleukin-18 and interleukin-12 potently induces interleukin-8 production by natural killer cells
SM Poznanski, AJ Lee, T Nham, E Lusty, MJ Larché, DA Lee, AA Ashkar
Journal of Innate Immunity 9 (5), 511-525, 2017
372017
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
AL Portillo, R Hogg, SM Poznanski, EA Rojas, NJ Cashell, JA Hammill, ...
Iscience 24 (6), 2021
352021
Shining light on the significance of NK cell CD56 brightness
SM Poznanski, AA Ashkar
Cellular & molecular immunology 15 (12), 1071-1073, 2018
292018
Type I interferon receptor on NK cells negatively regulates interferon-γ production
AJ Lee, F Mian, SM Poznanski, M Stackaruk, T Chan, MV Chew, ...
Frontiers in immunology 10, 1261, 2019
262019
Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells
F Vahedi, T Nham, SM Poznanski, MV Chew, MM Shenouda, D Lee, ...
Scientific reports 7 (1), 12083, 2017
242017
Expanded human NK cells from lung cancer patients sensitize patients’ PDL1− negative tumors to PD1-blockade therapy
SM Poznanski, TM Ritchie, IY Fan, A El-Sayes, AL Portillo, R Ben-Avi, ...
Journal for immunotherapy of cancer 9 (1), 2021
232021
Type I interferon signalling is not required for the induction of endotoxin tolerance
Y Karimi, SM Poznanski, F Vahedi, B Chen, MV Chew, AJ Lee, AA Ashkar
Cytokine 95, 7-11, 2017
132017
Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection
AJ Lee, E Feng, MV Chew, E Balint, SM Poznanski, E Giles, A Zhang, ...
PLoS Pathogens 18 (5), e1010471, 2022
72022
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity
SM Poznanski, A Portillo, M Mukherjee, A Bhalla, K Son, AA Ashkar, ...
European Respiratory Journal 59 (4), 2022
32022
Recent advances in the use of NK cells against cancer
AE Gillgrass, T Krneta, SM Poznanski, AA Ashkar
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 327-348, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20